Prevalence of lipodystrophy and risk factors for dyslipidemia in HIV-infected children in Brazil

被引:12
作者
Papi, Luanda [1 ]
Menezes, Ana Carolina G. B. [1 ]
Rocha, Helio [2 ]
Abreu, Thalita F. [2 ]
de Oliveira, Ricardo Hugo [2 ]
Frota, Ana Cristina C. [2 ]
Evangelista, Lucia de A. [2 ]
Hofer, Cristina B. [1 ]
机构
[1] Univ Fed Rio de Janeiro, Rio de Janeiro, RJ, Brazil
[2] Univ Fed Rio de Janeiro, Dept Pediat, Rio de Janeiro, RJ, Brazil
关键词
HIV; Lipodystrophy; Dyslipidemia; Children; ANTIRETROVIRAL THERAPY; PROTEASE INHIBITORS; METABOLIC-CHANGES; ADOLESCENTS;
D O I
10.1016/j.bjid.2013.12.007
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of present study was to describe the frequency of lipodystrophy syndrome associated with HIV (LSHIV) and factors associated with dyslipidemia in Brazilian HIV infected children. HIV infected children on antiretroviral treatment were evaluated (nutritional assessment, physical examination, and laboratory tests) in this cross-sectional study. Univariate analysis was performed using Mann-Whitney test or Fisher's exact test followed by logistic regression analysis. Presence of dyslipidemia (fasting cholesterol >200 mg/dl or triglycerides >130 mg/dl) was the dependent variable. 90 children were enrolled. The mean age was 10.6 years (3-16 years), and 52 (58%) were female. LSHIV was detected in 46 children (51%). Factors independently associated with dyslipidemia were: low intake of vegetables/fruits (OR = 3.47, 95%CI = 1.04-11.55), current use of lopinavir/ritonavir (OR = 2.91, 95%CI = 1.11-7.67). In conclusion, LSHN was frequently observed; inadequate dietary intake of sugars and fats, as well as current use of lopinavir/ritonavir was associated with dyslipidemia. (C) 2014 Elsevier Editora Ltda. All rights reserved.
引用
收藏
页码:394 / 399
页数:6
相关论文
共 25 条
[1]   Body Fat Abnormality in HIV-Infected Children and Adolescents Living in Europe: Prevalence and Risk Factors [J].
Alam, Naufil ;
Cortina-Borja, Mario ;
Goetghebuer, Tessa ;
Marczynska, Magdalena ;
Vigano, Alessandra ;
Thorne, Claire .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 (03) :314-324
[2]   Dietary intake and dyslipidemia arising from combination antiretroviral therapy for HIV infection: a systematic review [J].
Almeida, Luara Bellinghausen ;
Giudici, Kelly Virecoulon ;
Jaime, Patricia Constante .
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2009, 53 (05) :519-527
[3]  
[Anonymous], 2008, NUTR GESTACAO AO ENV
[4]  
Arpadi SM, 2001, J ACQ IMMUN DEF SYND, V27, P30, DOI 10.1097/00126334-200105010-00005
[5]  
Aurpibul L, 2007, ANTIVIR THER, V12, P1247
[6]   Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children [J].
Beregszaszi, M ;
Dollfus, C ;
Levine, M ;
Faye, A ;
Deghmoun, S ;
Bellal, N ;
Houang, M ;
Chevenne, D ;
Hankard, R ;
Bresson, JL ;
Blanche, SP ;
Levy-Marchal, C .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (02) :161-168
[7]   Growth parameters in HIV-vertically-infected adolescents on antiretroviral therapy in Rio de Janeiro, Brazil [J].
Buonora, Sibelle ;
Nogueira, Susie ;
Pone, Marcus Vinicius ;
Aloe, Marisa ;
Oliveira, Ricardo Hugo ;
Hofer, Cristina .
ANNALS OF TROPICAL PAEDIATRICS, 2008, 28 (01) :59-64
[8]   A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].
Carr, A ;
Samaras, K ;
Burton, S ;
Law, M ;
Freund, J ;
Chisholm, DJ ;
Cooper, DA .
AIDS, 1998, 12 (07) :F51-F58
[9]   Dyslipidemia among perinatally HIV-infected children enrolled in the PACTS-HOPE cohort, 1999-2004: A longitudinal analysis [J].
Carter, RJ ;
Wiener, J ;
Abrams, EJ ;
Farley, J ;
Nesheim, S ;
Palumbo, P ;
Bulterys, M .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (04) :453-460
[10]   Use of HAART among young people living with HIV [J].
Comulada, WS ;
Swendeman, DT ;
Rotheram-Borus, MJ ;
Mattes, KM ;
Weiss, RE .
AMERICAN JOURNAL OF HEALTH BEHAVIOR, 2003, 27 (04) :389-400